Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Rheumatoid Arthritis

  Free Subscription


Articles published in Rheumatol Int

Retrieve available abstracts of 100 articles:
HTML format
Text format



Single Articles


    October 2018
  1. STEFFEN A, Holstiege J, Klimke K, Akmatov MK, et al
    Patterns of the initiation of disease-modifying antirheumatic drugs in incident rheumatoid arthritis: a German perspective based on nationwide ambulatory drug prescription data.
    Rheumatol Int. 2018 Oct 10. pii: 10.1007/s00296-018-4161.
    PubMed     Text format     Abstract available


  2. CASTREJON I, Shakoor N, Chua JR, Block JA, et al
    Discordance of global assessment by patients and physicians is higher in osteoarthritis than in rheumatoid arthritis: a cross-sectional study from routine care.
    Rheumatol Int. 2018 Oct 6. pii: 10.1007/s00296-018-4166.
    PubMed     Text format     Abstract available


    September 2018
  3. MUNOZ-FERNANDEZ S, Oton-Sanchez T, Carmona L, Calvo-Alen J, et al
    Use of prognostic factors of rheumatoid arthritis in clinical practice and perception of their predictive capacity before and after exposure to evidence.
    Rheumatol Int. 2018 Sep 24. pii: 10.1007/s00296-018-4152.
    PubMed     Text format     Abstract available


  4. COSKUN BENLIDAYI I
    Sleep impairment: an obstacle to achieve optimal quality of life in rheumatoid arthritis.
    Rheumatol Int. 2018 Sep 11. pii: 10.1007/s00296-018-4155.
    PubMed     Text format     Abstract available


  5. SAIKI O, Uda H
    Efficacy and safety of extending intravenous tocilizumab intervals from 4 to 6 weeks in rheumatoid arthritis patients with good response to 4-week intervals.
    Rheumatol Int. 2018 Sep 11. pii: 10.1007/s00296-018-4149.
    PubMed     Text format     Abstract available


  6. MCKENNA S, Tierney M, O'Neill A, Fraser A, et al
    Correction to: Sleep and physical activity: a cross-sectional objective profile of people with rheumatoid arthritis.
    Rheumatol Int. 2018 Sep 5. pii: 10.1007/s00296-018-4143.
    PubMed     Text format     Abstract available


    August 2018
  7. DEMMELMAIER I, Pettersson S, Nordgren B, Dufour AB, et al
    Associations between fatigue and physical capacity in people moderately affected by rheumatoid arthritis.
    Rheumatol Int. 2018 Aug 29. pii: 10.1007/s00296-018-4140.
    PubMed     Text format     Abstract available


  8. SAPUNDZHIEVA T, Karalilova R, Batalov A
    Musculoskeletal ultrasound for predicting remission in patients with rheumatoid arthritis: results from a 1-year prospective study.
    Rheumatol Int. 2018 Aug 18. pii: 10.1007/s00296-018-4131.
    PubMed     Text format     Abstract available


    July 2018
  9. YU X, Li Z, Ren M, Xi J, et al
    Superb microvascular imaging (SMI) for evaluating hand joint lesions in patients with rheumatoid arthritis in clinical remission.
    Rheumatol Int. 2018 Jul 30. pii: 10.1007/s00296-018-4112.
    PubMed     Text format     Abstract available


  10. SAWADA H, Suda M, Rokutanda R, Kobayashi D, et al
    Concomitant use of intravenous methylprednisolone to increase retention rate of abatacept in rheumatoid arthritis.
    Rheumatol Int. 2018 Jul 27. pii: 10.1007/s00296-018-4115.
    PubMed     Text format     Abstract available


  11. CEA-CALVO L, Raya E, Marras C, Salman-Monte TC, et al
    Correction to: The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern.
    Rheumatol Int. 2018 Jul 25. pii: 10.1007/s00296-018-4113.
    PubMed     Text format     Abstract available


  12. AYRAVAINEN L, Heikkinen AM, Kuuliala A, Ahola K, et al
    Activity of rheumatoid arthritis correlates with oral inflammatory burden.
    Rheumatol Int. 2018 Jul 24. pii: 10.1007/s00296-018-4108.
    PubMed     Text format     Abstract available


  13. WALTER MJM, Kuijper TM, Hazes JMW, Weel AE, et al
    Fatigue in early, intensively treated and tight-controlled rheumatoid arthritis patients is frequent and persistent: a prospective study.
    Rheumatol Int. 2018 Jul 16. pii: 10.1007/s00296-018-4102.
    PubMed     Text format     Abstract available


  14. YOSHIDA T, Hashimoto M, Kawahara R, Yamamoto H, et al
    Non-obese visceral adiposity is associated with the risk of atherosclerosis in Japanese patients with rheumatoid arthritis: a cross-sectional study.
    Rheumatol Int. 2018 Jul 4. pii: 10.1007/s00296-018-4095.
    PubMed     Text format     Abstract available


    June 2018
  15. CEA-CALVO L, Raya E, Marras C, Salman-Monte TC, et al
    The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern.
    Rheumatol Int. 2018 Jun 29. pii: 10.1007/s00296-018-4097.
    PubMed     Text format     Abstract available


  16. SALAFFI F, Di Carlo M, Carotti M, Sarzi-Puttini P, et al
    The subjective components of the Disease Activity Score 28-joints (DAS28) in rheumatoid arthritis patients and coexisting fibromyalgia.
    Rheumatol Int. 2018 Jun 28. pii: 10.1007/s00296-018-4096.
    PubMed     Text format     Abstract available


  17. MEEK B, Kelder JC, Claessen AME, van Houte AJ, et al
    Rheumatoid factor isotype and Ro epitope distribution in primary Sjogren syndrome and rheumatoid arthritis with keratoconjunctivitis sicca.
    Rheumatol Int. 2018 Jun 23. pii: 10.1007/s00296-018-4090.
    PubMed     Text format     Abstract available


  18. VALOR L, Garrido J, Martinez-Estupinan L, Hernandez-Florez D, et al
    Identifying markers of sustained remission in rheumatoid arthritis patients on long-term tapered biological disease-modifying antirheumatic drugs.
    Rheumatol Int. 2018 Jun 18. pii: 10.1007/s00296-018-4087.
    PubMed     Text format     Abstract available


  19. CASTRO LL, Lanna CCD, Rocha MP, Ribeiro ALP, et al
    Recognition and control of hypertension, diabetes, and dyslipidemia in patients with rheumatoid arthritis.
    Rheumatol Int. 2018 Jun 15. pii: 10.1007/s00296-018-4084.
    PubMed     Text format     Abstract available


  20. GUIMARAES MFBR, de Andrade MVM, Machado CJ, Vieira ELM, et al
    Leptin as an obesity marker in rheumatoid arthritis.
    Rheumatol Int. 2018 Jun 11. pii: 10.1007/s00296-018-4082.
    PubMed     Text format     Abstract available


    May 2018
  21. KABUL EG, Aslan UB, Basakci Calik B, Tasci M, et al
    Exploring the relation between impairment rating by DAS-28 and body function, activity participation, and environmental factors based on ICF hand core set in the patient with rheumatoid arthritis.
    Rheumatol Int. 2018 May 30. pii: 10.1007/s00296-018-4060.
    PubMed     Text format     Abstract available


  22. LEON L, Redondo M, Fernandez-Nebro A, Gomez S, et al
    Expert recommendations on the psychological needs of patients with rheumatoid arthritis.
    Rheumatol Int. 2018 May 28. pii: 10.1007/s00296-018-4057.
    PubMed     Text format     Abstract available


  23. LAUKOVA L, Konecna B, Vlkova B, Mlynarikova V, et al
    Anti-cytokine therapy and plasma DNA in patients with rheumatoid arthritis.
    Rheumatol Int. 2018 May 23. pii: 10.1007/s00296-018-4055.
    PubMed     Text format     Abstract available


  24. BISKUP M, Biskup W, Majdan M, Targonska-Stepniak B, et al
    Cardiovascular system changes in rheumatoid arthritis patients with continued low disease activity.
    Rheumatol Int. 2018 May 17. pii: 10.1007/s00296-018-4053.
    PubMed     Text format     Abstract available


  25. MCKENNA SG, Donnelly AE, Esbensen BA, Fraser AD, et al
    The impact of exercise on sleep (time, quality, and disturbance) in patients with rheumatoid arthritis: a study protocol for a pilot randomised controlled trial.
    Rheumatol Int. 2018 May 15. pii: 10.1007/s00296-018-4052.
    PubMed     Text format     Abstract available


  26. UDACHKINA HV, Novikova DS, Popkova TV, Kirillova IG, et al
    Dynamic of changes in coronary artery calcification in early rheumatoid arthritis patients over 18 months.
    Rheumatol Int. 2018 May 11. pii: 10.1007/s00296-018-4045.
    PubMed     Text format     Abstract available


  27. NIKFAR S, Saiyarsarai P, Tigabu BM, Abdollahi M, et al
    Efficacy and safety of interleukin-1 antagonists in rheumatoid arthritis: a systematic review and meta-analysis.
    Rheumatol Int. 2018 May 8. pii: 10.1007/s00296-018-4041.
    PubMed     Text format     Abstract available


  28. MANDAL SK, Sandhya P, Kabeerdoss J, Ramya J, et al
    CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjogren's syndrome.
    Rheumatol Int. 2018;38:831-836.
    PubMed     Text format     Abstract available


    April 2018
  29. MEYER PWA, Ally MTM, Hodkinson B, Anderson R, et al
    Comparison of the diagnostic potential of three anti-citrullinated protein antibodies as adjuncts to rheumatoid factor and CCP in a cohort of South African rheumatoid arthritis patients.
    Rheumatol Int. 2018 Apr 30. pii: 10.1007/s00296-018-4036.
    PubMed     Text format     Abstract available


  30. BOUTRUP RJ, Farup J, Vissing K, Kjaer M, et al
    Skeletal muscle stem cell characteristics and myonuclei content in patients with rheumatoid arthritis: a cross-sectional study.
    Rheumatol Int. 2018 Apr 12. pii: 10.1007/s00296-018-4028.
    PubMed     Text format     Abstract available


  31. DORNER TE, Berner C, Haider S, Grabovac I, et al
    Sexual health in patients with rheumatoid arthritis and the association between physical fitness and sexual function: a cross-sectional study.
    Rheumatol Int. 2018 Apr 11. pii: 10.1007/s00296-018-4023.
    PubMed     Text format     Abstract available


  32. RADOVANOVIC-DINIC B, Tesic-Rajkovic S, Zivkovic V, Grgov S, et al
    Clinical connection between rheumatoid arthritis and liver damage.
    Rheumatol Int. 2018 Apr 7. pii: 10.1007/s00296-018-4021.
    PubMed     Text format     Abstract available


  33. HIGGINS SC, Adams J, Hughes R
    Measuring hand grip strength in rheumatoid arthritis.
    Rheumatol Int. 2018 Apr 6. pii: 10.1007/s00296-018-4024.
    PubMed     Text format     Abstract available


  34. MARTIN-LOPEZ M, Carmona L, Balsa A, Calvo-Alen J, et al
    Serum drug levels of biologic agents in the management of rheumatoid arthritis and spondyloarthritis: a systematic review.
    Rheumatol Int. 2018 Apr 3. pii: 10.1007/s00296-018-4022.
    PubMed     Text format     Abstract available


    March 2018
  35. BODAKCI E, Uskudar Cansu D, Erturk A, Calisir C, et al
    Can neck pain be an initial symptom of rheumatoid arthritis? A case report and literature review.
    Rheumatol Int. 2018 Mar 27. pii: 10.1007/s00296-018-4019.
    PubMed     Text format     Abstract available


  36. FAUTREL B, Alten R, Kirkham B, de la Torre I, et al
    Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis.
    Rheumatol Int. 2018 Mar 21. pii: 10.1007/s00296-018-4005.
    PubMed     Text format     Abstract available


  37. TENTEN-DIEPENMAAT M, van der Leeden M, Vliet Vlieland TPM, Roorda LD, et al
    The effectiveness of therapeutic shoes in patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Rheumatol Int. 2018 Mar 20. pii: 10.1007/s00296-018-4014.
    PubMed     Text format     Abstract available


  38. MCKENNA S, Tierney M, O'Neill A, Fraser A, et al
    Sleep and physical activity: a cross-sectional objective profile of people with rheumatoid arthritis.
    Rheumatol Int. 2018 Mar 14. pii: 10.1007/s00296-018-4009.
    PubMed     Text format     Abstract available


  39. SALGADO E, Maneiro Fernandez JR, Souto Vilas A, Gomez-Reino JJ, et al
    Spanish transcultural adaptation and validation of the English version of the compliance questionnaire in rheumatology.
    Rheumatol Int. 2018;38:467-472.
    PubMed     Text format     Abstract available


    February 2018
  40. MARCHI LF, Paoliello-Paschoalato AB, Oliveira RDR, Azzolini AECS, et al
    Activation status of peripheral blood neutrophils and the complement system in adult rheumatoid arthritis patients undergoing combined therapy with infliximab and methotrexate.
    Rheumatol Int. 2018 Feb 20. pii: 10.1007/s00296-018-3997.
    PubMed     Text format     Abstract available


  41. HASEGAWA M, Sakai F, Konda N, Okabayashi A, et al
    CT assessment of axillary lymphadenopathy in patients with rheumatoid arthritis: association with disease activity and severity.
    Rheumatol Int. 2018 Feb 12. pii: 10.1007/s00296-018-3992.
    PubMed     Text format     Abstract available


  42. SIALA M, Rihl M, Sellami H, Znazen A, et al
    Detection of Shigella spp. nucleic acids in the synovial tissue of Tunisian rheumatoid arthritis patients and other forms of arthritis by quantitative real-time polymerase chain reaction.
    Rheumatol Int. 2018 Feb 5. pii: 10.1007/s00296-018-3939.
    PubMed     Text format     Abstract available


    January 2018
  43. LOPEZ-LONGO FJ, Seoane-Mato D, Martin-Martinez MA, Sanchez-Alonso F, et al
    Variability in the prescription of biological drugs in rheumatoid arthritis in Spain: a multilevel analysis.
    Rheumatol Int. 2018 Jan 24. pii: 10.1007/s00296-018-3933.
    PubMed     Text format     Abstract available


  44. KARAGULLE M, Kardes S, Karagulle MZ
    Long-term efficacy of spa therapy in patients with rheumatoid arthritis.
    Rheumatol Int. 2018 Jan 11. pii: 10.1007/s00296-017-3926.
    PubMed     Text format     Abstract available


  45. WON S, Cho SK, Kim D, Han M, et al
    Update on the prevalence and incidence of rheumatoid arthritis in Korea and an analysis of medical care and drug utilization.
    Rheumatol Int. 2018 Jan 4. pii: 10.1007/s00296-017-3925.
    PubMed     Text format     Abstract available


  46. TADA M, Inui K, Sugioka Y, Mamoto K, et al
    Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study.
    Rheumatol Int. 2018 Jan 2. pii: 10.1007/s00296-017-3922.
    PubMed     Text format     Abstract available


  47. SIGHART R, Rech J, Hueber A, Blank N, et al
    Evidence for genetic overlap between adult onset Still's disease and hereditary periodic fever syndromes.
    Rheumatol Int. 2018;38:111-120.
    PubMed     Text format     Abstract available


    December 2017
  48. PEREZ-ROMAN DI, Ortiz-Haro AB, Ruiz-Medrano E, Contreras-Yanez I, et al
    Outcomes after rheumatoid arthritis patients complete their participation in a long-term observational study with tofacitinib combined with methotrexate: practical and ethical implications in vulnerable populations after tofacitinib discontinuation.
    Rheumatol Int. 2017 Dec 20. pii: 10.1007/s00296-017-3910.
    PubMed     Text format     Abstract available


  49. FORSYTH C, Kouvari M, D'Cunha NM, Georgousopoulou EN, et al
    The effects of the Mediterranean diet on rheumatoid arthritis prevention and treatment: a systematic review of human prospective studies.
    Rheumatol Int. 2017 Dec 18. pii: 10.1007/s00296-017-3912.
    PubMed     Text format     Abstract available


  50. SANTOS-MORENO P, Alvis-Zakzuk NJ, Villarreal-Peralta L, Carrasquilla-Sotomayor M, et al
    A comprehensive care program achieves high remission rates in rheumatoid arthritis in a middle-income setting. Experience of a Center of Excellence in Colombia.
    Rheumatol Int. 2017 Dec 16. pii: 10.1007/s00296-017-3903.
    PubMed     Text format     Abstract available


  51. OLIVIER N, Burger J, Joubert R, Lubbe M, et al
    Chronic disease list conditions in patients with rheumatoid arthritis in the private healthcare sector of South Africa.
    Rheumatol Int. 2017 Dec 12. pii: 10.1007/s00296-017-3907.
    PubMed     Text format     Abstract available


  52. GIANFRANCESCO MA, Yazdany J, Schmajuk G
    The impact of smoking on disease measures in rheumatoid arthritis: the need for appropriate adjustment of time-varying confounding.
    Rheumatol Int. 2017 Dec 5. pii: 10.1007/s00296-017-3902.
    PubMed     Text format     Abstract available


  53. KAMATA Y, Minota S
    Wide difference in biologics usage and expenditure for the treatment of patients with rheumatoid arthritis in each prefecture in Japan analyzed using "National Database of Health Insurance Claims and Specific Health Checkups of Japan".
    Rheumatol Int. 2017 Dec 5. pii: 10.1007/s00296-017-3900.
    PubMed     Text format     Abstract available


    November 2017
  54. DO ESPIRITO SANTO RC, Pompermayer MG, Bini RR, Olszewski V, et al
    Neuromuscular fatigue is weakly associated with perception of fatigue and function in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Nov 27. pii: 10.1007/s00296-017-3894.
    PubMed     Text format     Abstract available


  55. BAGANZ L, Richter A, Kekow J, Bussmann A, et al
    Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort.
    Rheumatol Int. 2017 Nov 16. doi: 10.1007/s00296-017-3870.
    PubMed     Text format     Abstract available


  56. AKYUZ G, Kenis-Coskun O
    The Efficacy of Tai Chi and Yoga in Rheumatoid Arthritis and Spondyloarthropathies: A narrative biomedical review.
    Rheumatol Int. 2017 Nov 4. doi: 10.1007/s00296-017-3867.
    PubMed     Text format     Abstract available


    October 2017
  57. UDACHKINA HV, Novikova DS, Popkova TV, Kirillova IG, et al
    Calcification of coronary arteries in early rheumatoid arthritis prior to anti-rheumatic therapy.
    Rheumatol Int. 2017 Oct 27. doi: 10.1007/s00296-017-3860.
    PubMed     Text format     Abstract available


  58. SKALKOU A, Manoli SM, Sachinidis A, Ntouros V, et al
    Pyoderma gangrenosum and pyogenic arthritis presenting as severe sepsis in a rheumatoid arthritis patient treated with golimumab.
    Rheumatol Int. 2017 Oct 26. doi: 10.1007/s00296-017-3861.
    PubMed     Text format     Abstract available


  59. TAN YK, Allen JC Jr, Lye WK, Chew LC, et al
    Greater rheumatoid arthritis joint improvement with more subjects achieving response across improvement categories using novel versus existing ultrasound methods.
    Rheumatol Int. 2017 Oct 20. doi: 10.1007/s00296-017-3857.
    PubMed     Text format     Abstract available


  60. LARKIN L, Gallagher S, Fraser A, Kennedy N, et al
    Community-based intervention to promote physical activity in rheumatoid arthritis (CIPPA-RA): a study protocol for a pilot randomised control trial.
    Rheumatol Int. 2017 Oct 17. doi: 10.1007/s00296-017-3850.
    PubMed     Text format     Abstract available


  61. LEE KE, Lee SS
    In reply to the letter to the Editor, "HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis".
    Rheumatol Int. 2017 Oct 17. doi: 10.1007/s00296-017-3851.
    PubMed     Text format    


  62. WENG J, Wu H, Wang Z
    HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis: methodological issues.
    Rheumatol Int. 2017 Oct 17. doi: 10.1007/s00296-017-3849.
    PubMed     Text format    


  63. KUME K, Amano K, Yamada S, Kanazawa T, et al
    Tofacitinib improves atherosclerosis despite up-regulating serum cholesterol in patients with active rheumatoid arthritis: a cohort study.
    Rheumatol Int. 2017 Oct 14. doi: 10.1007/s00296-017-3844.
    PubMed     Text format     Abstract available


  64. QUINTANA-DUQUE MA, Rondon-Herrera F, Calvo-Paramo E, Yunis JJ, et al
    The impact of smoking on disease activity, disability, and radiographic damage in rheumatoid arthritis: is cigarette protective?
    Rheumatol Int. 2017 Oct 11. doi: 10.1007/s00296-017-3845.
    PubMed     Text format     Abstract available


  65. BERNARDES M, Vieira T, Lucas R, Pereira J, et al
    Serum serotonin levels and bone in rheumatoid arthritis patients.
    Rheumatol Int. 2017 Oct 9. doi: 10.1007/s00296-017-3836.
    PubMed     Text format     Abstract available


    September 2017
  66. LEE KE, Choi SE, Xu H, Kang JH, et al
    HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Sep 27. doi: 10.1007/s00296-017-3833.
    PubMed     Text format     Abstract available


  67. SCHIRMER M, Lion V
    Decline of rheumatologic care of nursing home residents with rheumatoid arthritis.
    Rheumatol Int. 2017 Sep 8. doi: 10.1007/s00296-017-3810.
    PubMed     Text format    


  68. SUGIMOTO N, Nakajima A, Inoue E, Shidara K, et al
    Incidence of comprehensive hospitalization due to infection, cardiovascular disease, fractures, and malignancies in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Sep 7. doi: 10.1007/s00296-017-3811.
    PubMed     Text format     Abstract available


  69. SALAFFI F, Gerardi MC, Atzeni F, Batticciotto A, et al
    The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis.
    Rheumatol Int. 2017 Sep 5. doi: 10.1007/s00296-017-3792.
    PubMed     Text format     Abstract available


  70. YOON BY, Lee JH, Shin SY
    Discrepancy between subjective and objective measures of cognitive impairment in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Sep 4. doi: 10.1007/s00296-017-3806.
    PubMed     Text format     Abstract available


    August 2017
  71. LAU CS, Gibofsky A, Damjanov N, Lula S, et al
    Down-titration of biologics for the treatment of rheumatoid arthritis: a systematic literature review.
    Rheumatol Int. 2017 Aug 29. doi: 10.1007/s00296-017-3780.
    PubMed     Text format     Abstract available


  72. LUQUE RAMOS A, Albrecht K, Zink A, Hoffmann F, et al
    Rheumatologic care of nursing home residents with rheumatoid arthritis: a comparison of the year before and after nursing home admission.
    Rheumatol Int. 2017 Aug 18. doi: 10.1007/s00296-017-3791.
    PubMed     Text format     Abstract available


  73. LI G, Zhao J, Li B, Ma J, et al
    Associations between CCL21 gene polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis.
    Rheumatol Int. 2017 Aug 10. doi: 10.1007/s00296-017-3784.
    PubMed     Text format     Abstract available


    July 2017
  74. KIM D, Cho SK, Choi CB, Choe JY, et al
    Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Jul 26. doi: 10.1007/s00296-017-3781.
    PubMed     Text format     Abstract available


  75. AZIZIEH FY, Al Jarallah K, Shehab D, Gupta R, et al
    Patterns of circulatory and peripheral blood mononuclear cytokines in rheumatoid arthritis.
    Rheumatol Int. 2017 Jul 19. doi: 10.1007/s00296-017-3774.
    PubMed     Text format     Abstract available


  76. HIRVONEN H, Kautiainen H, Moilanen E, Mikkelsson M, et al
    The effect of cryotherapy on total antioxidative capacity in patients with active seropositive rheumatoid arthritis.
    Rheumatol Int. 2017 Jul 11. doi: 10.1007/s00296-017-3771.
    PubMed     Text format     Abstract available


  77. TAN BE, Lim AL, Kan SL, Lim CH, et al
    Real-world clinical experience of biological disease modifying anti-rheumatic drugs in Malaysia rheumatoid arthritis patients.
    Rheumatol Int. 2017 Jul 10. doi: 10.1007/s00296-017-3772.
    PubMed     Text format     Abstract available


  78. GALARZA-DELGADO DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, et al
    Prevalence of comorbidities in Mexican mestizo patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Jul 5. doi: 10.1007/s00296-017-3769.
    PubMed     Text format     Abstract available


    June 2017
  79. GOH LL, Yong MY, See WQ, Chee EYW, et al
    NLRP1, PTPN22 and PADI4 gene polymorphisms and rheumatoid arthritis in ACPA-positive Singaporean Chinese.
    Rheumatol Int. 2017 Jun 26. doi: 10.1007/s00296-017-3762.
    PubMed     Text format     Abstract available


  80. MENA-VAZQUEZ N, Manrique-Arija S, Yunquera-Romero L, Urena-Garnica I, et al
    Adherence of rheumatoid arthritis patients to biologic disease-modifying antirheumatic drugs: a cross-sectional study.
    Rheumatol Int. 2017 Jun 19. doi: 10.1007/s00296-017-3758.
    PubMed     Text format     Abstract available


  81. HUSNI ME, Betts KA, Griffith J, Song Y, et al
    Benefit-risk trade-offs for treatment decisions in moderate-to-severe rheumatoid arthritis: focus on the patient perspective.
    Rheumatol Int. 2017 Jun 16. doi: 10.1007/s00296-017-3760.
    PubMed     Text format     Abstract available


  82. CARDENAS MJ, de la Fuente S, Castro-Villegas MC, Romero-Gomez M, et al
    Optimization of biological therapy in rheumatoid arthritis patients: outcomes from the CREATE registry after 2 years of follow-up.
    Rheumatol Int. 2017 Jun 9. doi: 10.1007/s00296-017-3757.
    PubMed     Text format     Abstract available


  83. PAVELKA K, Akkoc N, Al-Maini M, Zerbini CAF, et al
    Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access.
    Rheumatol Int. 2017 Jun 9. doi: 10.1007/s00296-017-3749.
    PubMed     Text format     Abstract available


    May 2017
  84. WEIJERS L, Baerwald C, Mennini FS, Rodriguez-Heredia JM, et al
    Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada.
    Rheumatol Int. 2017 May 30. doi: 10.1007/s00296-017-3739.
    PubMed     Text format     Abstract available


  85. RONDINA RG, de Mello RAF, Valim V, Lourenco RB, et al
    Discordance between clinical and imaging criteria: assessment by magnetic resonance imaging of the foot of patients with rheumatoid arthritis.
    Rheumatol Int. 2017 May 27. doi: 10.1007/s00296-017-3754.
    PubMed     Text format     Abstract available


  86. TZANETAKOS C, Tzioufas A, Goules A, Kourlaba G, et al
    Cost-utility analysis of certolizumab pegol in combination with methotrexate in patients with moderate-to-severe active rheumatoid arthritis in Greece.
    Rheumatol Int. 2017 May 18. doi: 10.1007/s00296-017-3736.
    PubMed     Text format     Abstract available


  87. MARRAS C, Monteagudo I, Salvador G, de Toro FJ, et al
    Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-study.
    Rheumatol Int. 2017 May 17. doi: 10.1007/s00296-017-3737.
    PubMed     Text format     Abstract available


  88. SONG X, Lin Q
    Genomics, transcriptomics and proteomics to elucidate the pathogenesis of rheumatoid arthritis.
    Rheumatol Int. 2017 May 10. doi: 10.1007/s00296-017-3732.
    PubMed     Text format     Abstract available


  89. KABASAKAL Y, Kitapcioglu G, Karabulut G, Tezcan M, et al
    Criteria sets for primary Sjogren's syndrome are not adequate for those presenting with extraglandular organ involvements as their dominant clinical features.
    Rheumatol Int. 2017;37:675-684.
    PubMed     Text format     Abstract available


  90. LLORENTE I, Merino L, Ortiz AM, Escolano E, et al
    Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients.
    Rheumatol Int. 2017;37:799-806.
    PubMed     Text format     Abstract available


  91. STREVENS BOLMGREN V, Olsson P, Wollmer P, Hesselstrand R, et al
    Respiratory symptoms are poor predictors of concomitant chronic obstructive pulmonary disease in patients with primary Sjogren's syndrome.
    Rheumatol Int. 2017;37:813-818.
    PubMed     Text format     Abstract available


    April 2017
  92. HUNTER TM, Boytsov NN, Zhang X, Schroeder K, et al
    Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014.
    Rheumatol Int. 2017 Apr 28. doi: 10.1007/s00296-017-3726.
    PubMed     Text format     Abstract available


  93. TADA M, Inui K, Sugioka Y, Mamoto K, et al
    Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study.
    Rheumatol Int. 2017 Apr 12. doi: 10.1007/s00296-017-3720.
    PubMed     Text format     Abstract available


  94. TAN BE, Lim AL, Kan SL, Lim CH, et al
    Management of rheumatoid arthritis in clinical practice using treat-to-target strategy: Where do we stand in the multi-ethnic Malaysia population?
    Rheumatol Int. 2017 Apr 7. doi: 10.1007/s00296-017-3705.
    PubMed     Text format     Abstract available


  95. DE MIGUEL E, Pecondon-Espanol A, Castano-Sanchez M, Corrales A, et al
    A reduced 12-joint ultrasound examination predicts lack of X-ray progression better than clinical remission criteria in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Apr 7. doi: 10.1007/s00296-017-3714.
    PubMed     Text format     Abstract available


  96. NG WF, Miller A, Bowman SJ, Price EJ, et al
    Physical activity but not sedentary activity is reduced in primary Sjogren's syndrome.
    Rheumatol Int. 2017;37:623-631.
    PubMed     Text format     Abstract available


  97. GARCIA-MONTOYA L, Saenz-Tenorio CN, Janta I, Menarguez J, et al
    Hemophagocytic lymphohistiocytosis in a patient with Sjogren's syndrome: case report and review.
    Rheumatol Int. 2017;37:663-669.
    PubMed     Text format     Abstract available


    March 2017
  98. STOLT M, Suhonen R, Leino-Kilpi H
    Foot health in patients with rheumatoid arthritis-a scoping review.
    Rheumatol Int. 2017 Mar 21. doi: 10.1007/s00296-017-3699.
    PubMed     Text format     Abstract available


  99. EL-HENAWY AA, Hafez EA, Nabih N, Shalaby NM, et al
    Anti-Toxoplasma antibodies in Egyptian rheumatoid arthritis patients.
    Rheumatol Int. 2017 Mar 20. doi: 10.1007/s00296-017-3703.
    PubMed     Text format     Abstract available


    June 2016
  100. JANTA I, Moran J, Naredo E, Nieto JC, et al
    How does a cadaver model work for testing ultrasound diagnostic capability for rheumatic-like tendon damage?
    Rheumatol Int. 2016;36:863-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: